Last Updated: May 11, 2026

Suppliers and packagers for macrilen


✉ Email this page to a colleague

« Back to Dashboard


macrilen

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Aeterna Zentaris MACRILEN macimorelin acetate FOR SOLUTION;ORAL 205598 NDA Novo Nordisk 0169-1401-01 1 POUCH in 1 CARTON (0169-1401-01) / 60 mg in 1 POUCH 2022-01-31
Aeterna Zentaris MACRILEN macimorelin acetate FOR SOLUTION;ORAL 205598 NDA Aeterna Zentaris GmbH 58844-130-01 1 POUCH in 1 CARTON (58844-130-01) / 60 mg in 1 POUCH 2018-01-29
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for macrilen

Last updated: April 26, 2026

What Companies Supply MACRILEN (macimorelin) Ingredients, Drug Product, and Key Inputs?

MACRILEN is the brand name of macimorelin, an oral ghrelin receptor agonist used in the diagnosis of adult growth hormone deficiency. Public, regulator-grade supplier visibility depends on the document set used (e.g., FDA labels, facility disclosures, drug master files, and CGT/DMF linkage). With that scope, I do not have sufficient sourced information in the provided prompt to produce a complete, accurate supplier map for MACRILEN (API manufacturers, formulation suppliers, fill-finish sites, packaging vendors, or CMOs).

Which suppliers (API, CMO, fill-finish, packaging) are confirmed for MACRILEN?

No supplier roster can be stated accurately from the information available in the prompt.


What supplier categories matter for MACRILEN commercialization?

A decision-ready supplier map for MACRILEN typically breaks into four buckets:

  1. API supply (macimorelin synthesis)
  2. Drug product manufacturing (formulation and tableting/capsule operations)
  3. Fill-finish and packaging
  4. Regulatory-linked technical inputs (analytical method transfer, stability program, DMF/CTD-referenced materials)

A complete answer requires direct sourcing for each category.


What can be stated about MACRILEN supplier identification from public regulatory artifacts?

Supplier identification is typically traceable through:

  • FDA prescribing information (often lists manufacturer(s) and distributor)
  • Facility inspection and establishment lists (can identify who manufactures finished dosage forms)
  • DMF-linked disclosures (API manufacturing and key intermediates)
  • Harmonized regulatory submissions (CTD section 3 manufacturing details)

None of these artifacts are provided in the prompt, so the supplier list cannot be completed without introducing unverified claims.


Key Takeaways

  • A supplier list for MACRILEN cannot be produced accurately from the provided information.
  • A decision-grade mapping requires sourced identification of API, drug product manufacturing, fill-finish, and packaging vendors.
  • No confirmed supplier entities for MACRILEN can be listed here without regulator-grade source evidence.

FAQs

Who makes the macimorelin API used in MACRILEN?

No confirmed API maker can be listed from the provided prompt.

Which company manufactures the finished MACRILEN dosage form?

No confirmed finished-dose manufacturer can be listed from the provided prompt.

Who performs fill-finish and packaging for MACRILEN?

No confirmed fill-finish or packaging vendor can be listed from the provided prompt.

Are MACRILEN suppliers listed on the US FDA label?

The prompt does not include the label text or manufacturer/distributor section needed to extract suppliers.

Can supplier details be derived from DMFs or CTD manufacturing sections?

Not from the information provided; DMF/CTD linkage is not included in the prompt.


References

[1] No sources were provided in the prompt to cite.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.